Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
multiple dose studies multiple dose studies multiple dose studies multiple dose studies	Loky do	2024-03-04 10:27	3	2024-03-12 17:37	734
Statistical Method and acceptance	Vismayi	2024-01-23 09:29	0		614
Steady state BE study dosing Circadian rhythm? Steady state BE study dosing AUC in steady state AUC in steady state AUC in steady state	NK	2024-01-19 04:24	5	2024-01-27 22:16	1,338
Mizolastine study design	Bebac user	2023-12-20 18:47	0		626
Single-dose study in patients Single-dose study in patients Single-dose study in patients	Brus	2023-12-09 17:45	2	2023-12-11 10:44	1,104
Ebastine study design Ebastine study design	Bebac user	2023-11-25 13:07	1	2023-11-27 09:53	1,254
Amlodipine/Valsartan Amlodipine/Valsartan Amlodipine/Valsartan Amlodipine/Valsartan Amlodipine/Valsartan Use all data and avoid the partial replicate design for the FDA	Bebac user	2023-09-09 06:34	5	2023-12-07 09:01	1,897
crossover design when use RSABE with two test products RSABE with two test products RSABE with two test products RSABE with two test products: Sample size? RSABE with two test products: Sample size? RSABE with two test products crossover design when use ABEL with two test products crossover design when use ABEL with two test products crossover design when use ABEL with two test products	Darborn	2023-08-22 02:24	8	2024-02-25 09:59	2,165
Adhesion Score Analysis	durga09	2023-07-17 11:15	0		1,203
Stabilization period Stabilization period Stabilization period	Vismayi	2023-06-26 19:55	2	2023-06-30 15:13	1,245
SD crossover study with no washout any examples SD crossover study with no washout any examples SD crossover study with no washout any examples	Achievwin	2023-06-19 16:37	2	2023-06-20 14:48	1,244
Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Definition of Full Replicate Full Replicate with 3 periods Full Replicate with 3 periods Full Replicate with 3 periods Definition of Full Replicate Replicate Design ≠ Higher-Order Crossover Thank You! Replicate Design ≠ Higher-Order Crossover imbalance in Latin Square Balance for all effects	Sereng	2023-03-13 17:08	13	2023-04-21 10:01	3,088
EU Transdermal Patch: Generic Submission	HallaGulla	2023-03-08 08:58	0		1,003
Documentation of SS for LAI Documentation of SS for LAI	Achievwin	2023-02-06 13:40	1	2023-02-28 16:50	1,735
Study Design: Two treatment or Four treatment Study Design: Two treatment or Four treatment Study Design: Two treatment or Four treatment Study Design: Two treatment or Four treatment Study Design: Two treatment or Four treatment	NK	2023-01-23 09:38	4	2023-01-24 03:37	2,282